<?xml version="1.0" encoding="utf8"?>
 <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd"> <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">IJIP</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Infection Prevention</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2690-4837</issn>
      <publisher>
        <publisher-name>Open Access Pub</publisher-name>
        <publisher-loc>United States</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.14302/issn.2690-4837.ijip-21-4015</article-id>
      <article-id pub-id-type="publisher-id">IJIP-21-4015</article-id>
      <article-categories>
        <subj-group>
          <subject>research-article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Theory on the Impact of Copper and Micronutrients Against              COVID-19 in Humans </article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Caitlin</surname>
            <given-names>A. Connor DAOM PGDip AMP EHP-C</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842871596">1</xref>
          <xref ref-type="aff" rid="idm1842870660">2</xref>
          <xref ref-type="aff" rid="idm1842887628">*</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1842871596">
        <label>1</label>
        <addr-line>Health Sciences Research, Rewley House, University of Oxford, UK. </addr-line>
      </aff>
      <aff id="idm1842870660">
        <label>2</label>
        <addr-line>Principle Investigator, Earthsongs Holistic Consulting. </addr-line>
      </aff>
      <aff id="idm1842887628">
        <label>*</label>
        <addr-line>Corresponding author</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Jigar</surname>
            <given-names>Modi</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842736308">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1842736308">
        <label>1</label>
        <addr-line>Postdoctoral Fellow, Neuroscience, Florida Atlantic University.</addr-line>
      </aff>
      <author-notes>
        <corresp>
  Caitlin Connor, <addr-line>Health Sciences Research, Rewley House, University of Oxford, UK. </addr-line><addr-line>Principle Investigator, Earthsongs Holistic                   Consulting</addr-line>. <email>caitlin_connor@mindspring.com</email></corresp>
        <fn fn-type="conflict" id="idm1843050892">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub" iso-8601-date="2021-11-27">
        <day>27</day>
        <month>11</month>
        <year>2021</year>
      </pub-date>
      <volume>1</volume>
      <issue>3</issue>
      <fpage>1</fpage>
      <lpage>8</lpage>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>11</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>11</month>
          <year>2021</year>
        </date>
        <date date-type="online">
          <day>27</day>
          <month>11</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© </copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Caitlin Connor</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://openaccesspub.org/ijip/article/1735">This article is available from http://openaccesspub.org/ijip/article/1735</self-uri>
      <abstract>
        <p>Copper (Cu) has a strong impact on the function of the immune system through several different pathways. These impacts include helping the function of monocytes, neutrophils, and               macrophages, and enhancing Natural Killer cells’ activities. Cu also has a role in antimicrobial               properties and inflammatory response. It is also important for IL-2 production and response, which is a component of adaptive immune cells.            Additionally, Cu has multiple roles in both                    proliferation and differentiation of T cells and is                involved in the production of antibodies. Cu                      deficiency can even lead to "increased viral                       virulence"<xref ref-type="bibr" rid="ridm1842443108">1</xref>. Copper has a long history of use in medicine, and has continued to be used for                       purification of water, including use in hospitals to prevent legionnaires disease. The CDC pre released information on a study completed in March 2020 on the lifespan of COVID-19 on different surfaces which included its lifespan on copper, where it was                     completely dead within 4 hours. In addition, "Several reports demonstrated that Cu deficiency weakens the human immune response" <xref ref-type="bibr" rid="ridm1842449596">2</xref>. Given the multiple avenues of impact, it has been suggested that Cu        supplementation, within recommended levels,  be given to individuals who are low in Cu to help them fight off COVID-19. It is also possible that Cu                      supplementation, within recommended levels, may help prevent COVID-19 infection, or help individuals who are not low in Cu to fight off COVID-19 infection. However, dosage would have to be carefully                   managed, as excess levels of Cu can lead to both             neurodegenerative and neurodevelopmental               diseases. </p>
      </abstract>
      <kwd-group>
        <kwd>COVID-19</kwd>
        <kwd>SARS COV 2</kwd>
        <kwd>Copper Files</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <page-count count="8"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="idm1842735156" sec-type="intro">
      <title>Introduction </title>
      <p>The duality of copper is important to remember when investigating its effects on the human body. In                    excess, copper can cause severe negative health issues, which include "cirrhosis and chronic hepatitis,                     neurodegeneration, parkinsonian features, seizures, and psychiatric symptoms such as psychosis" <xref ref-type="bibr" rid="ridm1842519644">3</xref>. In contrast to these issues "...copper is fundamental to life as we know it, and that there can be no such life without copper" <xref ref-type="bibr" rid="ridm1842302068">4</xref>. A number of necessary processes in the human body are mediated by copper. Included in these are several aspects of immune function. Copper also has a long history of use as an antimicrobial agent, both internally and externally <xref ref-type="bibr" rid="ridm1842298612">5</xref>, including recent evidence of its impact on the length of survival of the COVID-19 virus on surfaces <xref ref-type="bibr" rid="ridm1842289580">6</xref>. While                 research on the impact of copper directly on SARS-CoV-2 is limited at this time, research on similar and related                viruses can be used to guide theory. "Furthermore, in vitro studies show that copper ions block a fundamental protein for SARS-CoV-1 replication. Hence, copper has antiviral properties acting at two levels: enhancing the components of the immune system to fight against infections and by direct contact with virus" <xref ref-type="bibr" rid="ridm1842285044">7</xref>. This combination suggests that copper may help individuals who have been exposed to COVID-19 to fight off infection. </p>
      <sec id="idm1842735084">
        <title>SARS-CoV-2</title>
        <p>Coronaviridae are a family of viruses identified by their "contained RNA surrounded by a membrane                  composed of “spike”-shaped proteins" <xref ref-type="bibr" rid="ridm1842272228">8</xref>. "The                  crown-like appearance of these surface “spike” proteins gave the virus family the name - “corona” being Latin for crown" <xref ref-type="bibr" rid="ridm1842272228">8</xref>. One of these viruses, specifically SARS-CoV-2,  was declared a pandemic by the WHO on March 11,                2020 <xref ref-type="bibr" rid="ridm1842272228">8</xref>. SARS-CoV-2 spike proteins are used to attach to cells at the angiotensin-converting enzyme 2 (ACE2)               receptor <xref ref-type="bibr" rid="ridm1842272228">8</xref>. This receptor is the same location used by SARS-CoV <xref ref-type="bibr" rid="ridm1842272228">8</xref>, suggesting that interventions that were   successful against SARS-CoV infection might also work against SARS-CoV-2. Once SARS-CoV-2 has attached to a cell it "it integrates its RNA into the cell’s own replication machinery, facilitating propagation of the virus" <xref ref-type="bibr" rid="ridm1842272228">8</xref>. "Symptoms of the virus are similar to MERS and SARS, and include fever, cough, and shortness of breath", though COVID-19 has proven to be "significantly more infectious than SARS and MERS in terms of human-to-human               transmission" <xref ref-type="bibr" rid="ridm1842272228">8</xref>. The difference between SARS and COVID in viral load at symptom development, meaning that COVID can be transmitted prior to symptom                  development, also makes it more difficult to contain <xref ref-type="bibr" rid="ridm1842272228">8</xref>. </p>
      </sec>
    </sec>
    <sec id="idm1842734940">
      <title>Background</title>
      <p>Copper has been shown in the past to attack               multiple different types of viruses <xref ref-type="bibr" rid="ridm1842298612">5</xref><xref ref-type="bibr" rid="ridm1842267836">9</xref><xref ref-type="bibr" rid="ridm1842248284">10</xref>. These virus types have specifically included SARS-CoV-1 <xref ref-type="bibr" rid="ridm1842285044">7</xref>, HIV,             Polio <xref ref-type="bibr" rid="ridm1842298612">5</xref>, type A influenza virus <xref ref-type="bibr" rid="ridm1842443108">1</xref>, and M. tuberculosis, where the immune system responded by creating an    overload of copper and zinc in the phagosome <xref ref-type="bibr" rid="ridm1842248284">10</xref>.               Copper has also been shown to decrease infectiousness within two minutes in a Norovirus strand <xref ref-type="bibr" rid="ridm1842267836">9</xref>. The CDC prereleased information on a study completed in March 2020 on the lifespan of COVID-19 on different surfaces <xref ref-type="bibr" rid="ridm1842289580">6</xref>. This included the lifespan on copper, where the virus was completely dead within 4 hours <xref ref-type="bibr" rid="ridm1842289580">6</xref>. </p>
      <p>In addition to the direct effects of copper on              viruses, copper appears to have a beneficial effect on the immune system. "Copper has previously been implicated in the regulation of immune responses..." <xref ref-type="bibr" rid="ridm1842260236">11</xref>. It should also be noted that, aside from decreasing the microbial burden itself, copper has also demonstrated an                      antimicrobial effect on its surroundings, even outside of the immediate environment. This effect has been tested and remained consistent for 21 months <xref ref-type="bibr" rid="ridm1842257644">12</xref>"The levels of antimicrobial activity of the metallic copper surfaces were equivalent throughout the course of the trial" <xref ref-type="bibr" rid="ridm1842257644">12</xref>. "The most surprising finding was the 64% decrease in MB                between the preintervention and intervention phases in the control rooms" <xref ref-type="bibr" rid="ridm1842257644">12</xref>.</p>
    </sec>
    <sec id="idm1842732564">
      <title>History</title>
      <p>Copper has a long history of use in medicine, starting with use in the purification of drinking water and the treatment of burns in Egypt in 2000 BC <xref ref-type="bibr" rid="ridm1842298612">5</xref>. The use of copper for the purification of water continued through Greece in 400 BC to early American pioneers, who placed copper coins in water casks, and in WWII, where Japanese soldiers used pieces of copper in water bottles to prevent dysentery <xref ref-type="bibr" rid="ridm1842298612">5</xref>. It was also used by the Greeks in 400 BC for pulmonary diseases, a treatment that was repeated in the 18th century, when it became widely used clinically for both lung and mental issues <xref ref-type="bibr" rid="ridm1842298612">5</xref>. The Roman Empire used cooking utensils made from copper to prevent disease spread <xref ref-type="bibr" rid="ridm1842298612">5</xref>. Skin conditions were treated using copper    oxide, as well as malachite, by the Aztecs, and are still treated using copper sulphate by some residents of Africa and Asia <xref ref-type="bibr" rid="ridm1842298612">5</xref>. It has continued to be used for purification of water to this day, including use in hospitals to prevent legionnaires disease <xref ref-type="bibr" rid="ridm1842298612">5</xref> It also has EPA approval for use as an antimicrobial surface <xref ref-type="bibr" rid="ridm1842298612">5</xref></p>
      <sec id="idm1842732636">
        <title>Biochemistry- Copper’s Effects on Viruses </title>
        <p>Copper has been shown in the past to have a               negative impact on multiple different types of                          viruses <xref ref-type="bibr" rid="ridm1842298612">5</xref><xref ref-type="bibr" rid="ridm1842267836">9</xref><xref ref-type="bibr" rid="ridm1842248284">10</xref>. Copper ions have been shown to directly attack viruses in two different ways, using two different types of ions. The first, Cu(II), attacks the capsid                    barrier <xref ref-type="bibr" rid="ridm1842267836">9</xref>. This starts with the virus’s receptor sites,               immediately limiting its ability to infect individuals even prior to virus death <xref ref-type="bibr" rid="ridm1842267836">9</xref>. This process has been shown to decrease infectiousness within two minutes in a Norovirus strand <xref ref-type="bibr" rid="ridm1842267836">9</xref>. Research in 1993 by Sagripanti et al. showed that after 30 minutes, 99% of the virus was inactivated in vitro, caused by Cu(II) <xref ref-type="bibr" rid="ridm1842223652">13</xref>. The second ion, Cu(I), goes after the genome <xref ref-type="bibr" rid="ridm1842217244">14</xref>. Borkow <xref ref-type="bibr" rid="ridm1842298612">5</xref> showed that one of the nucleic acids forms covalent bonds with copper, and in the process divides the genome into pieces <xref ref-type="bibr" rid="ridm1842298612">5</xref>. This                   nucleotide can occur as often as every three                         nucleotides <xref ref-type="bibr" rid="ridm1842298612">5</xref>, which means that the genome divides into progressively smaller sections over time <xref ref-type="bibr" rid="ridm1842217244">14</xref>. This has been seen to start within 15 minutes and leaves no viable virus within 2 hours <xref ref-type="bibr" rid="ridm1842267836">9</xref>. The DNA damage has been found to occur even with nanoparticles of copper, and not just with solid objects <xref ref-type="bibr" rid="ridm1842214220">15</xref>. Cu(II) also "can inhibit RNA                 polymerase activity by more than 60%, with copper            exhibiting the strongest effect compared to other metal ions" <xref ref-type="bibr" rid="ridm1842223652">13</xref>. The damage to viral DNA and RNA also means that the genomic information will not be available for             other viruses to integrate and mutate <xref ref-type="bibr" rid="ridm1842217244">14</xref>. Research has also suggested that enveloped viruses are more strongly affected by Cu(II) inactivation, and that RNA and lipids may increase sensitivity of viral particles to this                inactivation <xref ref-type="bibr" rid="ridm1842223652">13</xref>. It is very important to remember that the covalent bonds formed between copper and nucleic acids also means that other, stronger, bonds can distract the copper molecules <xref ref-type="bibr" rid="ridm1842298612">5</xref>. These include glutathione and cysteine <xref ref-type="bibr" rid="ridm1842298612">5</xref>. The human body has been shown to use               particularly high concentrations of specific                               micronutrients, including copper, internal to various              immune cells, to destroy viral particles <xref ref-type="bibr" rid="ridm1842201980">16</xref>. This                 specifically includes macrophages <xref ref-type="bibr" rid="ridm1842201980">16</xref>. In addition to               these very direct attacks on the virus itself, research              suggests that copper can interfere with proteins which produce functions that are important for the virus <xref ref-type="bibr" rid="ridm1842223652">13</xref>.</p>
      </sec>
      <sec id="idm1842752452">
        <title>Biochemistry- Copper’s Effects on the Human Body</title>
        <p>More research still needs to be done on the             mechanisms of copper in the human body, but the           research that has been done so far has resulted in some interesting findings. The first is that there is almost no free or unused copper present in the human body. It is usually bound to another substance, and usually for a specific     purpose. The current research suggests that copper is most commonly a cofactor for either electron transport proteins or specific enzymes that are involved in                     antioxidant or energy metabolism <xref ref-type="bibr" rid="ridm1842302068">4</xref>, though copper                deficiency also appears to affect every cell, as "copper is required for the assembly and activity of complex IV of the mitochondrial respiratory chain" <xref ref-type="bibr" rid="ridm1842519644">3</xref> and impairment of this chain due to copper insufficiency appears to produce enlarged mitochondria, as is seen in Menkes disease <xref ref-type="bibr" rid="ridm1842519644">3</xref>. "Cuproenzymes are involved in oxidizing metals and             organic substrates and produce a wide array of                         metabolites, neuropeptides, pigments and many other biologically active compounds" <xref ref-type="bibr" rid="ridm1842201980">16</xref>. In addition to these functions, copper has been linked to apoptosis and                autophagy, which "has been demonstrated to have an           antiviral response to viral oxidative stress" <xref ref-type="bibr" rid="ridm1842223652">13</xref>. This            response helps to limit viral infection <xref ref-type="bibr" rid="ridm1842223652">13</xref>. "The copper/autophagy interconnection opens potential therapeutic application studies and clinical development of copper to target COVID-19 infection" <xref ref-type="bibr" rid="ridm1842223652">13</xref>. "The functions of these copper dependent enzymes alone make it abundantly clear that copper is fundamental to life as we know it, and that there can be no such life without copper" <xref ref-type="bibr" rid="ridm1842302068">4</xref>. </p>
        <p>Copper seems to have a role in almost every, if not every, stage of immune response <xref ref-type="bibr" rid="ridm1842443108">1</xref>. "Copper can boost the host’s immune system response against pathogens, exhibiting strong antibacterial, antifungal, antiviral and anti inflammatory (<italic>sic</italic>) effects" <xref ref-type="bibr" rid="ridm1842223652">13</xref>. Ongoing research has "established that the complex, integrated immune system needs multiple specific micronutrients, including vitamins A, D, C, E, B6, and B12, folate, zinc, iron, copper, and                 selenium, which play vital, often synergistic roles at every stage of the immune response" <xref ref-type="bibr" rid="ridm1842443108">1</xref>. The first stage of the immune response includes physical and biochemical               barriers to entry. While copper does not have a clear role in this stage, it does have an impact on the proper          formation and function of connective tissue and collagen maturation, both of which are likely to impact the physical barrier aspects <xref ref-type="bibr" rid="ridm1842302068">4</xref>. Once this stage has been bypassed, the role of copper becomes much clearer. The second stage of immune response is one of innate immunity. This stage primarily consists of an inflammatory process involving phagocytes, Natural Killer (NK) cells, and antimicrobial substances in blood serum response <xref ref-type="bibr" rid="ridm1842443108">1</xref>. Copper                 specifically "has intrinsic antimicrobial properties that destroy a wide range of microorganisms" <xref ref-type="bibr" rid="ridm1842443108">1</xref>. Once the anti microbial defenses have been bypassed, NK cells are              activated <xref ref-type="bibr" rid="ridm1842443108">1</xref>. Once infected cells are destroyed by NK cells, neutrophils and macrophages migrate to the area and  destroy any released microbes through phagocytosis <xref ref-type="bibr" rid="ridm1842443108">1</xref>. Copper specifically helps the function of monocytes,                 neutrophils, and macrophages, and enhances NK cells’ activities <xref ref-type="bibr" rid="ridm1842443108">1</xref>. Phagocytosis also produces Reactive Oxygen Species (ROS) or a respiratory burst, where copper is key in the defense against damage from both. Copper can also trigger the formation of an ROS specifically to kill                    pathogens <xref ref-type="bibr" rid="ridm1842443108">1</xref>. The inflammatory response is triggered by a large number of different types of immune factors, as well as an increase in blood flow to the area to dilute any external factors that may have entered through the                      trauma <xref ref-type="bibr" rid="ridm1842443108">1</xref>. It also helps to repair the local damage. As part of this inflammation response, "copper is important for the production and response of IL-2 to adaptive immune cells and accumulates at the sites of inflammation" <xref ref-type="bibr" rid="ridm1842443108">1</xref>. Metallothioneins containing copper are also among the oxygen radical scavengers released at inflammation sites by immune cells <xref ref-type="bibr" rid="ridm1842302068">4</xref>.</p>
        <p>The third step in an immune response takes more time to implement, as it requires immune cells to                  recognize the pathogen and replicate prior to                           effectiveness. These cells are sorted into two main                  categories, T cells and B cells. Copper is specifically                   important to the differentiation and proliferation of T    lymphocytes, a subcategory of T cells <xref ref-type="bibr" rid="ridm1842443108">1</xref>. Once immune cells have recognized a pathogen and T or B cells have been implemented, future immune responses are much faster <xref ref-type="bibr" rid="ridm1842443108">1</xref>. Copper also plays a role in the signal that                   activates T cells, as well as T-cell proliferation and the   activity of NK immune cells <xref ref-type="bibr" rid="ridm1842443108">1</xref>. Additionally, copper is involved in the production of antibodies, which neutralize the invading agent and draw phagocytes to the area <xref ref-type="bibr" rid="ridm1842443108">1</xref>. It even appears that copper can trigger both apoptosis and autophagy, both of which protect cells <xref ref-type="bibr" rid="ridm1842223652">13</xref>. Copper               deficiency can even lead to "Increased viral virulence" <xref ref-type="bibr" rid="ridm1842443108">1</xref> as well as "less effective immune responses against              infections" <xref ref-type="bibr" rid="ridm1842285044">7</xref>. "Consistent with this evidence, it has been hypothesized that the optimal state of plasma copper            levels can increase both innate and adaptive immunity, even exerting an effect as a preventive and therapeutic factor against COVID-19" <xref ref-type="bibr" rid="ridm1842285044">7</xref>.</p>
      </sec>
      <sec id="idm1842751876">
        <title>Changes in Copper Amounts in the Body due to Infection</title>
        <p>An interesting factor in the human immune               response as relates to copper is that a recognized mark of an infection, regardless of the type, is a clear and                         continuing increase in copper in blood serum <xref ref-type="bibr" rid="ridm1842201980">16</xref>. It is likely that this is due to an increase in ceruloplasmin             levels in the blood as a reaction to inflammation <xref ref-type="bibr" rid="ridm1842223652">13</xref><xref ref-type="bibr" rid="ridm1842201980">16</xref>. An increase in IL-6 levels has also been shown to increase the amount of ceruloplasmin in the blood <xref ref-type="bibr" rid="ridm1842223652">13</xref>. "Since one molecule of ceruloplasmin binds 6 atoms of copper, even a modest increase in ceruloplasmin during infection can account for a substantial elevation in serum copper" <xref ref-type="bibr" rid="ridm1842201980">16</xref>. It has been suggested that the increase in copper may be an attempt to decrease inflammation, and that                      inflammatory diseases may be due to an insufficient               anti-inflammatory response due to low levels of stored copper <xref ref-type="bibr" rid="ridm1842223652">13</xref>. In contrast to the changing levels of copper due to infection, studies analyzing copper absorption have shown that levels of copper absorption remain the same after 2.5 mg. <xref ref-type="bibr" rid="ridm1842223652">13</xref>. This suggests that there is no benefit to consumption beyond that point, even during an active         infection. </p>
      </sec>
      <sec id="idm1842752812">
        <title>Zinc</title>
        <p>The T cells specifically look at antigen markers that code individual cells as self or non-self. Zinc has a fair amount to do with regulation of this stage of immune function and maintaining immune tolerance through              triggering the development of Regulatory T cells (Treg cells) and reducing   inflammatory factors <xref ref-type="bibr" rid="ridm1842443108">1</xref>. Even "The proliferation of cytotoxic T cells is induced by zinc" <xref ref-type="bibr" rid="ridm1842443108">1</xref>. "Microarray analysis of T-lymphocyte population changes in moderate zinc deficiency showed changes in expression of 1200 genes related to the proliferation, survival, and response of T-cells" <xref ref-type="bibr" rid="ridm1842443108">1</xref>. It is even "essential for intracellular binding of tyrosine kinase to T cell receptors, required for T cell development, differentiation, and activation; induces development of Treg cells and is thus important in                 maintaining immune tolerance" <xref ref-type="bibr" rid="ridm1842443108">1</xref>.  Zinc also decreases inflammation by decreasing the development of Th17 and Th9 cells and impacts the "generation of cytokines such as IL-2, IL-6, and TNF-alpha" <xref ref-type="bibr" rid="ridm1842443108">1</xref>. Unfortunately zinc also binds to the same transport molecules that copper does, which means that an increase in zinc also inhibits copper absorption. "Abnormally high concentrations of                    Zn(I1)   (30-100:l) and perhaps also of Fe(II/III) directly or indirectly inhibit uptake and transfer of copper from the diet to the blood" <xref ref-type="bibr" rid="ridm1842302068">4</xref>. This is even used as a standard treatment for high levels of copper in Wilsons disease <xref ref-type="bibr" rid="ridm1842519644">3</xref>.</p>
      </sec>
      <sec id="idm1842751516">
        <title>Negative Effects of Insufficient Copper </title>
        <p>There are negative impacts that arise from copper levels in the human body being either too low or too high. These impacts need to be understood when discussing the use of copper for health support. The impact of a sufficient lack of copper has been shown to include a lack of collagen maturation and improper elastic fiber sheathing of blood vessels <xref ref-type="bibr" rid="ridm1842302068">4</xref>. Copper is even critical to nerve signaling and stress responses through its enzymatic impact on the                      dopamine-norepinephrine-epinephrine cycle <xref ref-type="bibr" rid="ridm1842302068">4</xref>. Severe copper deficiency has been shown to impair production of norepinephrine in the brain, leading to accumulation of dopamine in specific areas <xref ref-type="bibr" rid="ridm1842302068">4</xref>. Animal studies have even suggested that both the synthesis of dopamine and                 myelination during development are copper                          dependent <xref ref-type="bibr" rid="ridm1842302068">4</xref>. Copper may also be able to reduce pain due to binding with enkephalin peptides, and has an              impact on new tissue development through                             angiogenesis <xref ref-type="bibr" rid="ridm1842302068">4</xref>. </p>
        <p>It has been previously established that certain nutrients are critical to the maintenance of the immune systems normal activity, including avoiding and defeating infections. "Specifically, the European Food Safety                  Authority (EFSA) evaluated and deems six vitamins (D, A, C, Folate, B6, B12) and four minerals (zinc, iron, copper and selenium) to be essential for the normal functioning of the immune system, due to the scientific evidence                    collected so far" <xref ref-type="bibr" rid="ridm1842285044">7</xref><xref ref-type="bibr" rid="ridm1842195428">17</xref>. This raises the question of how low these vitamins and minerals would have to be to cause a decrease in immune function <xref ref-type="bibr" rid="ridm1842443108">1</xref>. The research on this to date has had mixed results, but there is evidence that the supplementation of these micronutrients that have               documented immune support functions "may modulate immune function and reduce the risk of infection" <xref ref-type="bibr" rid="ridm1842443108">1</xref>. This is especially important as many individuals, even in               industrialized countries, often do not get enough of these micronutrients from their diet <xref ref-type="bibr" rid="ridm1842190676">18</xref>. This has specifically been observed with copper, among other nutrients <xref ref-type="bibr" rid="ridm1842285044">7</xref>. Surveys studying the diet in Europe have previously found widespread suboptimal intakes of these micronutrients, specifically including copper, with a range of 11% to 30%, including a high prevalence of insufficient intake in the elderly <xref ref-type="bibr" rid="ridm1842285044">7</xref>. "Furthermore, suboptimal copper intake (even without reaching critical deficiency) is associated with decreased T-cell proliferation and abnormalities in                  macrophage phagocytosis" <xref ref-type="bibr" rid="ridm1842285044">7</xref>. </p>
        <p>Unfortunately, there is currently little information on what level of deficient micronutrient status would              constitute suboptimal levels, and the health effects at that level of deficiency <xref ref-type="bibr" rid="ridm1842443108">1</xref>. It should also be noted that this will vary between different populations <xref ref-type="bibr" rid="ridm1842443108">1</xref>. This also means that there is insufficient information to establish optimal levels for the maintenance of immune function in differing individuals <xref ref-type="bibr" rid="ridm1842443108">1</xref>. The problem is particularly complicated by both the relatively stable absorption levels of copper               combined with the tendency for copper levels in serum to rise with infection. It is very important to note that "the European countries worst hit by the pandemic show                population% with suboptimal intake of vitamins and             minerals that are important to the immune system" <xref ref-type="bibr" rid="ridm1842285044">7</xref>. In combination with this, "a lower population% with covered needs of vitamin C, iron, and copper is related to higher relative mortality rates from COVID-19. Accordingly, the UK presents a large population% with suboptimal intake for these three micronutrients" <xref ref-type="bibr" rid="ridm1842285044">7</xref>. </p>
      </sec>
      <sec id="idm1842750868">
        <title>Negative Effects of Excess Copper </title>
        <p>Too much copper also has serious negative effects on the human body. For example, "ATP7B mutations lead to systemic accumulation of copper due to impaired               excretion by the liver" <xref ref-type="bibr" rid="ridm1842519644">3</xref>, and cause a subtype of           neurodegenerative and neurodevelopmental diseases <xref ref-type="bibr" rid="ridm1842519644">3</xref>. The damage done by excess copper is shown the most in the brain and liver <xref ref-type="bibr" rid="ridm1842519644">3</xref>. Specific symptoms of liver toxicity, as commonly demonstrated by individuals with Wilson disease, include "cirrhosis and chronic hepatitis,                        neurodegeneration, parkinsonian features, seizures, and psychiatric symptoms such as psychosis" <xref ref-type="bibr" rid="ridm1842519644">3</xref>. "Copper is a powerful trigger of Parkinson’s molecular pathology               including alpha-synuclein aggregation as well as oxidative damage of proteins, lipids, and mitochondria" <xref ref-type="bibr" rid="ridm1842519644">3</xref>. If levels of copper get high enough it can also be deposited in the eye, which creates a halo around the cornea called a              Kayser–Fleischer ring <xref ref-type="bibr" rid="ridm1842519644">3</xref>. It should also be noted that while Menkes disease (insufficient copper) and Wilson disease (excess copper) both cause neurodegeneration, the specific appearance of the neurodegeneration is very different. Specifically, Wilson disease mostly affects the brain after it has developed. "Wilson’s neurodegeneration encompasses the striatum and pallidum and to a minor degree cerebral cortex, brainstem, and dentate                       nucleus" <xref ref-type="bibr" rid="ridm1842519644">3</xref>. There is also "a more pronounced glial             pathology and signs of inflammation in Wilson                disease" <xref ref-type="bibr" rid="ridm1842519644">3</xref>. Wilson disease also produces distended                  mitochondria, though specifically in the liver and neurons, which possibly explains why those are the two organs most impacted by the disease. These distended                         mitochondria are likely caused by copper overload leading to the perikaryon having engorged organelles <xref ref-type="bibr" rid="ridm1842519644">3</xref>. While it has long been understood that copper can act as both a noxious agent or an enzymatic cofactor, it is also being discovered that it can also "operate as an allosteric                   modulator of signal transduction or a second messenger capable of integrating the metabolic activity of the Golgi complex, mitochondria, and plasma membrane metal transport" <xref ref-type="bibr" rid="ridm1842519644">3</xref>. These aspects may have unexplored               impacts on a range of insufficiently understood                       neurological disorders <xref ref-type="bibr" rid="ridm1842519644">3</xref>.</p>
      </sec>
    </sec>
    <sec id="idm1842750148" sec-type="conclusions">
      <title>Conclusion</title>
      <p>Copper has been shown in the past to have a              negative impact on the viability of multiple different types of viruses <xref ref-type="bibr" rid="ridm1842298612">5</xref><xref ref-type="bibr" rid="ridm1842267836">9</xref><xref ref-type="bibr" rid="ridm1842248284">10</xref>, both directly and indirectly. "Copper can boost the host’s immune system response against pathogens, exhibiting strong antibacterial, antifungal,             antiviral and antiinflammatory effects" <xref ref-type="bibr" rid="ridm1842223652">13</xref>. Ongoing              research has "established that the complex, integrated immune system needs multiple specific micronutrients, including vitamins A, D, C, E, B6, and B12, folate, zinc, iron, copper, and selenium, which play vital, often synergistic roles at every stage of the immune response" <xref ref-type="bibr" rid="ridm1842443108">1</xref>. It is very important to note that "the European countries worst hit by the pandemic show population% with suboptimal            intake of vitamins and minerals that are important to the immune system" <xref ref-type="bibr" rid="ridm1842285044">7</xref>. This combination of immune support with active antagonism to viral particles suggests that  copper may help individuals who have been exposed to COVID-19 fight off infection.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ridm1842443108">
        <label>1.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>A</surname>
            <given-names>F Gombart</given-names>
          </name>
          <name>
            <surname>Pierre</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Maggini</surname>
            <given-names>S</given-names>
          </name>
          <article-title>A Review of Micronutrients and the Immune System-Working</article-title>
          <date>
            <year>2020</year>
          </date>
          <chapter-title>in Harmony to Reduce the Risk of Infection. Nutrients. 2020 Jan 16;12(1): 236. doi: 10.3390/nu12010236. PMID: 31963293; PMCID: PMC7019735</chapter-title>
          <pub-id pub-id-type="doi">10.3390/nu12010236</pub-id>
          <pub-id pub-id-type="pmid">31963293</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842449596">
        <label>2.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Raha</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mallick</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Basak</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>A</surname>
            <given-names>K Duttaroy</given-names>
          </name>
          <article-title>Is copper beneficial for COVID-19 patients? Med Hypotheses</article-title>
          <date>
            <year>2020</year>
          </date>
          <volume>142</volume>
          <fpage>109814</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842519644">
        <label>3.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Hartwig</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>S</surname>
            <given-names>A Zlatic</given-names>
          </name>
          <name>
            <surname>Wallin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vrailas-Mortimer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>C</surname>
            <given-names>J Fahrni</given-names>
          </name>
          <name>
            <surname>Faundez</surname>
            <given-names>V</given-names>
          </name>
          <article-title>Trafficking mechanisms of P-type ATPase copper transporters</article-title>
          <date>
            <year>2019</year>
          </date>
          <source>Curr Opin Cell Biol</source>
          <volume>59</volume>
          <fpage>24</fpage>
          <lpage>33</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842302068">
        <label>4.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>M</surname>
            <given-names>C Linder</given-names>
          </name>
          <name>
            <surname>Hazegh-Azam</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Copper biochemistry and molecular biology.Am</article-title>
          <date>
            <year>1996</year>
          </date>
          <source>J ClinNutr</source>
          <volume>63</volume>
          <fpage>797</fpage>
          <lpage>811</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842298612">
        <label>5.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Borkow</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gabbay</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Copper, An Ancient Remedy Returning to Fight Microbial, Fungal and Viral Infections. Current Chemical Biology</article-title>
          <date>
            <year>2009</year>
          </date>
          <volume>3</volume>
          <issue>3</issue>
        </mixed-citation>
      </ref>
      <ref id="ridm1842289580">
        <label>6.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>N</surname>
            <given-names>Van Doremalen</given-names>
          </name>
          <name>
            <surname>Bushmaker</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Holbrook</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gamble</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Williamson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Tamin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Harcourt</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Thornburg</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gerber</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lloyd-Smith</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>E</surname>
            <given-names>de Wit</given-names>
          </name>
          <name>
            <surname>Munster</surname>
            <given-names>V</given-names>
          </name>
          <article-title>Aerosol and surface stability of HCoV-19 (SARS-CoV-6 2) compared to SARS-CoV-1</article-title>
          <date>
            <year>2020</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1842285044">
        <label>7.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Galmés</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Serra</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Palou</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Current State of Evidence:</article-title>
          <chapter-title>Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework. Nutrients. 2020 Sep 8;12(9): 2738. doi: 10.3390/nu12092738. PMID: 32911778; PMCID: PMC7551697</chapter-title>
          <pub-id pub-id-type="doi">10.3390/nu12092738</pub-id>
          <pub-id pub-id-type="pmid">32911778</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842272228">
        <label>8.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>C</surname>
            <given-names>L Atzrodt</given-names>
          </name>
          <name>
            <surname>Maknojia</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>McCarthy</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>T</surname>
            <given-names>M Oldfield</given-names>
          </name>
          <name>
            <surname>Po</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ta</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>H</surname>
            <given-names>E Stepp</given-names>
          </name>
          <name>
            <surname>T</surname>
            <given-names>P Clements</given-names>
          </name>
          <article-title>A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.The FEBS journal,287(17)</article-title>
          <date>
            <year>2020</year>
          </date>
          <fpage>3633</fpage>
          <lpage>3650</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842267836">
        <label>9.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>C</surname>
            <given-names>S Manuel</given-names>
          </name>
          <name>
            <surname>M</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>L</surname>
            <given-names>A Jaykus</given-names>
          </name>
          <date>
            <year>2015</year>
          </date>
          <chapter-title>Destruction of the Capsid and Genome of GII.4 Human Norovirus Occurs during Exposure to Metal Alloys Containing Copper.Applied and Environmental Microbiology</chapter-title>
          <volume>81</volume>
          <issue>15</issue>
          <fpage>4940</fpage>
          <lpage>4946</lpage>
          <pub-id pub-id-type="doi">10.1128/AEM.00388-15</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842248284">
        <label>10.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Neyrolles</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Wolschendorf</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Mitra</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Niederweis</surname>
            <given-names>M</given-names>
          </name>
          <date>
            <year>2015</year>
          </date>
          <chapter-title>Mycobacteria, metals, and the macrophage.Immunological Reviews</chapter-title>
          <volume>264</volume>
          <issue>1</issue>
          <fpage>249</fpage>
          <lpage>263</lpage>
          <pub-id pub-id-type="doi">10.1111/imr.12265</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842260236">
        <label>11.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Frisk</surname>
            <given-names>Hu</given-names>
          </name>
          <name>
            <surname>M</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kjellén</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>S</surname>
            <given-names>G Kaler</given-names>
          </name>
          <name>
            <surname>Pejler</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Öhrvik</surname>
            <given-names>H</given-names>
          </name>
          <date>
            <year>2017</year>
          </date>
          <chapter-title>Copper Regulates Maturation and Expression of an MITF: Tryptase Axis in Mast Cells.Journal of Immunology</chapter-title>
          <volume>199</volume>
          <issue>12</issue>
          <fpage>4132</fpage>
          <lpage>4141</lpage>
          <pub-id pub-id-type="doi">10.4049/jimmunol.1700786</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842257644">
        <label>12.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Schmidt</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Attaway</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sharpe</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>J</surname>
            <given-names/>
          </name>
          <name>
            <surname>Sepkowitz</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Morgan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fairey</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Steed</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>J</surname>
            <given-names>R Cantey</given-names>
          </name>
          <name>
            <surname>Freeman</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Michels</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Salgado</surname>
            <given-names>C</given-names>
          </name>
          <date>
            <year>2012</year>
          </date>
          <source>Sustained Reduction of Microbial Burden on Common Hospital Surfaces through Introduction of Copper. Journal of Clinical Microbiology</source>
          <volume>50</volume>
          <issue>7</issue>
          <fpage>2217</fpage>
          <lpage>2223</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.01032-12PMCID:</pub-id>
          <pub-id pub-id-type="pmid">22553242</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842223652">
        <label>13.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Andreou</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Trantza</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Filippou</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sipsas</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Tsiodras</surname>
            <given-names>S</given-names>
          </name>
          <article-title>COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2</article-title>
          <date>
            <year>2020</year>
          </date>
          <chapter-title>In Vivo. 2020 Jun;34(3 Suppl): 1567-1588. doi: 10.21873/invivo.11946. PMID:</chapter-title>
          <fpage>32503814</fpage>
          <pub-id pub-id-type="doi">10.21873/invivo.11946</pub-id>
          <pub-id pub-id-type="pmid">32503814</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842217244">
        <label>14.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Warnes</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Little</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Keevil</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials</article-title>
          <date>
            <year>2015</year>
          </date>
          <source>American Society for Microbiology</source>
          <volume>6</volume>
          <issue>6</issue>
          <fpage>01697</fpage>
          <lpage>15</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842214220">
        <label>15.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Fujimori</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sato</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hayata</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nagao</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nakayama</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nakayama</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sugamata</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Novel Antiviral Characteristics of Nanosized Copper(I) Iodide Particles Showing Inactivation Activity against</article-title>
          <date>
            <year>2012</year>
          </date>
          <chapter-title>Pandemic H1N1 Influenza Virus. Applied and Environmental Microbiology</chapter-title>
          <volume>78</volume>
          <issue>4</issue>
          <fpage>951</fpage>
          <lpage>955</lpage>
          <pub-id pub-id-type="doi">10.1128/AEM.06284-11PMCID:</pub-id>
          <pub-id pub-id-type="pmid">22156433</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842201980">
        <label>16.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>A</surname>
            <given-names>N Besold</given-names>
          </name>
          <name>
            <surname>E</surname>
            <given-names>M Culbertson</given-names>
          </name>
          <name>
            <surname>V</surname>
            <given-names>C Culotta</given-names>
          </name>
          <article-title>The Yin and Yang of copper during infection</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Biol Inorg Chem</source>
          <volume>21</volume>
          <issue>2</issue>
          <fpage>137</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.1007/s00775-016-1335-1</pub-id>
          <pub-id pub-id-type="pmid">26790881</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842195428">
        <label>17.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>P</surname>
            <given-names>C Calder</given-names>
          </name>
          <name>
            <surname>A</surname>
            <given-names>C Carr</given-names>
          </name>
          <name>
            <surname>A</surname>
            <given-names>F Gombart</given-names>
          </name>
          <name>
            <surname>Eggersdorfer</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections</article-title>
          <date>
            <year>2020</year>
          </date>
          <source>Nutrients</source>
          <volume>12</volume>
          <issue>4</issue>
          <fpage>1181</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842190676">
        <label>18.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Haryanto</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Suksmasari</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wintergerst</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Maggini</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Multivitamin Supplementation Supports Immune Function and Ameliorates Conditions Triggered By Reduced Air Quality</article-title>
          <date>
            <year>2015</year>
          </date>
          <source>Vitamins &amp; Minerals</source>
          <volume>3</volume>
          <fpage>128</fpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
